Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

BLOC1S5-TXNDC5 (BLOC1S5-TXNDC5 readthrough (NMD candidate))

Identity

Alias_namesMUTED-TXNDC5
MUTED-TXNDC5 readthrough (non-protein coding)
Other alias
HGNC (Hugo) BLOC1S5-TXNDC5
LocusID (NCBI) 100526836
Atlas_Id 60764
Location 6p24.3  [Link to chromosome band 6p24]
Location_base_pair Starts at 7881250 and ends at 8064414 bp from pter ( according to hg38-Dec_2013)
Fusion genes
(updated 2017)
Data from Atlas, Mitelman, Cosmic Fusion, Fusion Cancer, TCGA fusion databases with official HUGO symbols (see references in chromosomal bands)

Note

Non-annotated gene. Preliminary data : if you are an author
who wish to write a full paper/card on this gene, go to  How to contribute

DNA/RNA

 


External links

Nomenclature
HGNC (Hugo)BLOC1S5-TXNDC5   42001
Cards
Entrez_Gene (NCBI)BLOC1S5-TXNDC5  100526836  BLOC1S5-TXNDC5 readthrough (NMD candidate)
AliasesMUTED-TXNDC5
GeneCards (Weizmann)BLOC1S5-TXNDC5
Ensembl hg19 (Hinxton)ENSG00000259040 [Gene_View]
Ensembl hg38 (Hinxton)ENSG00000259040 [Gene_View]  ENSG00000259040 [Sequence]  chr6:7881250-8064414 [Contig_View]  BLOC1S5-TXNDC5 [Vega]
ICGC DataPortalENSG00000259040
TCGA cBioPortalBLOC1S5-TXNDC5
AceView (NCBI)BLOC1S5-TXNDC5
Genatlas (Paris)BLOC1S5-TXNDC5
WikiGenes100526836
SOURCE (Princeton)BLOC1S5-TXNDC5
Genetics Home Reference (NIH)BLOC1S5-TXNDC5
Genomic and cartography
GoldenPath hg38 (UCSC)BLOC1S5-TXNDC5  -     chr6:7881250-8064414 -  6p24.3   [Description]    (hg38-Dec_2013)
GoldenPath hg19 (UCSC)BLOC1S5-TXNDC5  -     6p24.3   [Description]    (hg19-Feb_2009)
EnsemblBLOC1S5-TXNDC5 - 6p24.3 [CytoView hg19]  BLOC1S5-TXNDC5 - 6p24.3 [CytoView hg38]
Mapping of homologs : NCBIBLOC1S5-TXNDC5 [Mapview hg19]  BLOC1S5-TXNDC5 [Mapview hg38]
Gene and transcription
Genbank (Entrez)BC052310
RefSeq transcript (Entrez)
RefSeq genomic (Entrez)
Consensus coding sequences : CCDS (NCBI)BLOC1S5-TXNDC5
Cluster EST : UnigeneHs.150837 [ NCBI ]
CGAP (NCI)Hs.150837
Alternative Splicing GalleryENSG00000259040
Gene ExpressionBLOC1S5-TXNDC5 [ NCBI-GEO ]   BLOC1S5-TXNDC5 [ EBI - ARRAY_EXPRESS ]   BLOC1S5-TXNDC5 [ SEEK ]   BLOC1S5-TXNDC5 [ MEM ]
Gene Expression Viewer (FireBrowse)BLOC1S5-TXNDC5 [ Firebrowse - Broad ]
SOURCE (Princeton)Expression in : [Datasets]   [Normal Tissue Atlas]  [carcinoma Classsification]  [NCI60]
BioGPS (Tissue expression)100526836
GTEX Portal (Tissue expression)BLOC1S5-TXNDC5
Human Protein AtlasENSG00000259040-BLOC1S5-TXNDC5 [pathology]   [cell]   [tissue]
Protein : pattern, domain, 3D structure
Domain families : Pfam (Sanger)
Domain families : Pfam (NCBI)
Conserved Domain (NCBI)BLOC1S5-TXNDC5
DMDM Disease mutations100526836
Blocks (Seattle)BLOC1S5-TXNDC5
Human Protein Atlas [tissue]ENSG00000259040-BLOC1S5-TXNDC5 [tissue]
IPIIPI00171438   IPI00154778   IPI00984716   IPI00982031   IPI01012126   IPI00946015   IPI00939560   
Protein Interaction databases
FunCoupENSG00000259040
BioGRIDBLOC1S5-TXNDC5
STRING (EMBL)BLOC1S5-TXNDC5
ZODIACBLOC1S5-TXNDC5
Ontologies - Pathways
Huge Navigator BLOC1S5-TXNDC5 [HugePedia]
snp3D : Map Gene to Disease100526836
BioCentury BCIQBLOC1S5-TXNDC5
ClinGenBLOC1S5-TXNDC5
Clinical trials, drugs, therapy
Chemical/Protein Interactions : CTD100526836
Clinical trialBLOC1S5-TXNDC5
Miscellaneous
canSAR (ICR)BLOC1S5-TXNDC5 (select the gene name)
Probes
Litterature
PubMed4 Pubmed reference(s) in Entrez
GeneRIFsGene References Into Functions (Entrez)
CoreMineBLOC1S5-TXNDC5
EVEXBLOC1S5-TXNDC5
GoPubMedBLOC1S5-TXNDC5
iHOPBLOC1S5-TXNDC5
Genes in titleautomatic search in PubMed
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Mon Jul 30 13:36:53 CEST 2018

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.